Lv31
250 积分 2024-09-25 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
5天前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
26天前
已完结
Study of the dynamic changes in the non-volatile chemical constituents of black tea during fermentation processing by a non-targeted metabolomics approach
27天前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
27天前
已完结
BAFF binding to T cell‐expressed BAFF‐R costimulates T cell proliferation and alloresponses
29天前
已完结
Anti-CD19 CAR T cell therapy for refractory SLE-ITP
1个月前
已完结
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?
2个月前
已完结
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-Up
2个月前
已完结
皖公网安备34019202002308
